Optimized polarization build-up times in dissolution DNP-NMR using a benzyl amino derivative of BDPA

J. L. Muñoz-Gómez ab, E. Monteagudoc, V. Lloverasab, T. Parellac, J. Veciana*ab and J. Vidal-Gancedo*ab
aInstitut de Ciència de Materials de Barcelona, (ICMAB-CSIC) Campus Universitari de Bellaterra, E-08193 Cerdanyola del Vallès, Spain. E-mail: j.vidal@icmab.es
bNetworking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain
cServei de Ressonància Magnètica Nuclear, Facultat de Ciències i Biociències, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Catalonia, Spain

Received 8th January 2016 , Accepted 18th February 2016

First published on 22nd February 2016


Abstract

The synthesis of two novel BDPA-like radicals, a benzyl amino (BAm-BDPA, 7) and a cyano (CN-BDPA, 5) derivative, is reported and their behaviour as polarizing agents for fast dissolution Dynamic Nuclear Polarization (DNP) is evaluated. The radical 7 is a promising candidate for DNP studies since it is soluble in neat [1-13C]pyruvic acid (PA), and therefore the use of an additional glassing agent for sample homogeneity is avoided. In addition, a 60 mM sample of 7 offers optimum 13C NMR signal enhancements using fairly short polarization times (about 1800 s). It is shown that DNP-NMR measurements using 7 can be performed much more efficiently in terms of the signal enhancement per polarization build-up time unit than when using the reference OX63 or BDPA radicals. These enhanced features are translated to a substantial reduction of polarization times that represents an optimum temporary use of the DNP polarizer and allow economized liquid helium consumption.


Introduction

Nuclear Magnetic Resonance (NMR) spectroscopy is an essential analytical technique widely used for the structural characterization and quantification of chemical compounds. On the other hand, Magnetic Resonance Imaging (MRI) has become a very important non-invasive tool in medicine for the early diagnosis of many diseases, for instance to obtain metabolic maps, anatomical and functional information, flux perfusion and diffusion studies, among others.1 The main drawback of NMR/MRI techniques is their poor sensitivity due to the inherent low thermal-equilibrium Boltzmann polarization of some interesting nuclear spins, such as the low natural-abundance of 13C and 15N. Different hyperpolarization methods2 have been developed to enhance the NMR signal, such as optical pumping,3,4 para-hydrogen induced polarization5,6 (PHIP) and dynamic nuclear polarization7–9 (DNP). Among them, dissolution DNP has become a powerful methodology for obtaining strongly polarized solutions for use in both in vitro and in vivo applications;10 for structural elucidation,11,12 to monitor chemical and biochemical reactions,13,14 to study molecular interactions,15 to develop new and ultrafast NMR experiments,16,17 to perform in vivo 13C imaging of metabolic reactions10,18 or in looking for new biomarkers by real-time molecular imaging.19,20 Recently, dissolution DNP has allowed real time assessment of low sensitivity nuclei such as 13C by in vivo NMR21 and the development of new pH-sensitive MRI agents.22 DNP experiments involve a sample containing an analyte, a source of free electrons, typically a radical molecule, and often a glassing agent solvent to ensure the sample homogeneity, leading to the proper polarization transfer from the unpaired electrons of the organic radical to the nearby nuclei of the analyte. Radicals such as TEMPO,23 BDPA,24 or trityl,25 have been widely used as mono- and/or biradicals as DNP polarizing agents.26 Nowadays, the most extended radical used for in vivo DNP applications is the trityl-based stable free radical OX63,27 mainly because it presents a narrow electron paramagnetic resonance (EPR) linewidth which enables polarization of low-γ nuclei. However, the OX63 radical is a very expensive commercial compound and soluble in the most common buffered solution conditions, hampering the translation of its hyperpolarizing features into human subject experiments. Additionally, it presents relatively long polarization build-up times (typically 60–90 min), with consequent time-consuming measurement and high helium consumption.

Recently, a carbon centered BDPA radical,24 (8 in Chart 1) and the benzyl alcohol derivative of BDPA (BA-BDPA)28 have been reported as new feasible polarizing agents for dissolution DNP. The original radical 8, which has a comparable EPR linewidth to OX63, is a versatile polarizing agent under a variety of sample conditions,29 from solid-state DNP30 to fast dissolution DNP of [1-13C]pyruvic acid (PA).31 In the latter case, although the residual BDPA radical traces can be removed from the hyperpolarized solution by filtration, its insolubility in neat PA requires the use of sulfolane as a glassing agent, limiting its application for in vivo experiments. On the other hand, the BA-BDPA radical is soluble in PA and can be easily removed from the hyperpolarized solution by in-line filtration.


image file: c6ra00635c-c1.tif
Chart 1 Structures of BDPA radical derivatives: CN-BDPA (5), BAm-BDPA (7) and the reference BDPA (8).

Herein, we report the synthesis and application as polarizing agents for dissolution DNP of two new BDPA derivatives: the benzyl amino BDPA (BAm-BDPA, 7, Chart 1) and the cyano (CN-BDPA, 5, Chart 1) radicals. Considering that a key step in dissolution DNP-NMR studies is the required polarization build-up time for an optimum signal enhancement, an experimental η factor (ε/saturation time) to measure the efficiency of the dissolution DNP-NMR process has been introduced. The general polarizing behavior and efficiency of radicals 5 and 7 in PA are analyzed and compared with the standards, BDPA and OX63.

Results and discussion

Synthesis and characterization

The reference radical 8 is remarkably stable to oxygen in the solid state32 and has been reported to be stable to oxygen in solution with the exclusion of light.33 However, to achieve the highest persistence in solution in the dark the presence of benzene is necessary to form a complex with the radical.33 On the other hand, the BDPA radical is reduced to give the corresponding carbanion when exposed to strong bases, such as hydroxide or alkoxide, and also reacts with strong acids.32

Radical 8 was firstly synthesized by the Koelsch’s method.32 Then, Kuhn and Neugebeauer developed an alternative method which involved fewer steps.34 Efforts to synthesize BDPA derivatives have been carried out by a few research groups,35,36 like Kuhn34 and Fox,33 and recently we have reported the synthesis of a benzyl alcohol derivative of BDPA (BA-BDPA).28 On the other hand, biradicals containing BDPA units have been limited only to molecules containing two BDPA radicals linked through the phenyl ring.34

In this work, the synthesis of the cyano BDPA derivative at the 4-position of the phenyl ring (4) was carried out following the Kuhn and Neugebeauer methodology,34 because it requires fewer steps and provides higher yields (Scheme 1). This multistep synthesis consisted of a condensation between fluorene and 4-cyanobenzaldehyde followed by a double bond bromination to obtain compound 2. The latter step was improved by changing the previously reported reaction conditions using sonication of suspended compound 1 in CCl4 for only five minutes. The next step was the elimination of hydrogen bromine to produce the conjugated acceptor 3, in a short reaction time (15 min) to avoid the possible hydrolysis of the cyano group. Finally, the allylic substitution of 3 added the final fluorene ring that completes the BDPA structure (4).


image file: c6ra00635c-s1.tif
Scheme 1 Synthetic scheme of BDPA derivatives. Reagents and conditions: (i) tBuOK, EtOH, reflux 16 h; (ii) Br2 in CCl4, room temperature, 5 min; (iii) NaOH in EtOH, reflux, 30 min; (iv) fluorene, tBuOK in DMA, room temperature, 15 min; (vi) LiAlH4 in THF, anhydrous; (v) and (vii) DBU in DCM, then AgNO3.

By reduction of the cyano derivative 4 with LiAlH4 in anhydrous THF at low temperature, the benzylamino derivative 6 was isolated after treatment in acid media (Scheme 1). This appeared as a slightly red colored solid suggesting the presence of minimum concentrations of a radical, as confirmed later by an EPR spectrum. Although the sample contained such radical traces, the NMR spectra could be obtained without problems.

Finally, radicals 5 and 7 were isolated by a treatment with 1,8-diazabicycloundec-7-ene (DBU), as a base, followed by AgNO3 as an oxidant agent in dichloromethane (DCM). The total yields of 5 and 7 were 74% and 52%, respectively. The carbanion formation and its oxidation to a radical were monitored by UV-Vis due to the different absorbance of the anion and radical forms. BDPA carbanion derivatives show an absorption band at around 600 nm and the radical form at around 495 nm. Thus, solutions of BDPA carbanion derivatives are in general blue colored, as is the case of radical 7, but in the case of radical 5 this was green due to the electron-withdrawing cyano group. However, the radical solutions were red in both cases, as for all reported BDPA radicals, because the electron density of the SOMO orbital is mainly located over the fluorenyl rings with a null perturbation of the substituted phenyl ring.37,38 The EPR spectra at room temperature and in frozen solutions of 5 and 7, as well as their corresponding simulations are depicted in Fig. S1–S3 of the ESI.

Dissolution DNP studies using BAm-BDPA (7) and CN-BDPA (5) radical derivatives

Due to the insolubility of radical 5 in neat PA, the samples were prepared using sulfolane as a co-solvent, as previously described for the BDPA radical.31 Thus, once the radical 5 was completely dissolved in 100 μl of sulfolane, the same amount of PA (100 μl) was added, obtaining a final 40 mM concentration of the radical in the mixture. The 13C microwave DNP spectrum (Fig. S4a), acquired with 100 μl of the previously prepared solution, shows a positive polarization peak at P(+) = 94.080 GHz (frequency of work) and the negative one at P(−) = 94.120 GHz. The polarization build-up curve (Fig. S4b) was obtained with a 30 μl aliquot of the frozen sample (40 mM) irradiated at the optimal frequency. A slow polarization build-up curve with a low polarization level was obtained, and, in addition, the sample was not stable with time (see ESI). Since the decomposition of the radical 5 could be the origin of such behavior,33 as occurs for the BDPA radical, several experiments with equimolar quantities of radical and benzene (see ESI) were repeated. However, the data obtained by the build-up curves were similar to those obtained in the previous case. Thus, it could be concluded that 5 is not a good polarizing agent of PA due to its low stability.

As noted before, radical BAm-BDPA 7 is soluble in neat PA thereby enabling its use without any glassing agent. A sample was prepared by dissolving 7 into PA and then an equimolar quantity of benzene was added giving a 40 mM concentration of 7. The acquisition of the 13C microwave DNP spectrum was carried out with an aliquot of 50 μl of the previous described sample and showed a positive polarization peak at 94.080 GHz and a negative one at 94.125 GHz (Fig. 1a). The separation between both polarization peaks (|P(+) − P(−)| = 94[thin space (1/6-em)]080–94[thin space (1/6-em)]125) was 45 MHz, which is an intermediate value between the non-functionalized BDPA radical24 (50 MHz) and the cyano derivative 5 (40 MHz). This could fulfill the requirements of polarizing 13C nuclei using the thermal mixing mechanism as the commercial BDPA radical does.31 The optimal frequency of work was determined as the positive peak polarization of P(+) = 94[thin space (1/6-em)]080 GHz.


image file: c6ra00635c-f1.tif
Fig. 1 (a) 13C microwave DNP spectrum of 50 μl [1-13C]pyruvic acid doped with 40 mM radical 7 at 3.35 T and 1.4 K. (b) Solid-state 13C polarization build-up curves of 20 μl [1-13C]pyruvic acid doped with different concentrations of radical 7.

Several samples were prepared (20, 40, 60 and 80 mM) to determine the optimal concentration of radical 7 for DNP experiments. The samples were made by dissolving the appropriate quantity of radical 7 into PA and adding an equimolar quantity of benzene. A 20 μl aliquot of each concentration was polarized at the optimal frequency until saturation, except for the 20 mM sample. As can be observed in Fig. 1b, the best polarization level in solid-state conditions was achieved for the 60 mM sample. The time needed to saturate the different samples was quite different depending on the radical concentration, decreasing at higher concentrations. It can be observed that the curve corresponding to the 20 mM sample is not saturated after 5400 s of polarization while the 60 mM sample only needs 1800 s to reach the maximum solid-state polarization level. In the case of the most concentrated 80 mM sample, saturation was achieved faster (1100 s) at the expense of a slightly lower enhancement. These saturation times are also reflected by an exponential decay in the build-up time constants (Tc, Fig. 2). The Tc value is lower at higher concentrations which could be associated with a thermal mixing mechanism.39


image file: c6ra00635c-f2.tif
Fig. 2 Build-up time constants (Tc) versus concentration of radical 7, OX63 and BDPA, performed at their optimal sample conditions in PA. Notice that BDPA includes sulfolane in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio.

After polarization, all the samples were fast dissolved in a hot water dissolution with Na2EDTA (743 μM) and automatically transferred to a 600 MHz NMR spectrometer to perform the corresponding 13C NMR measurements. The overall transfer time was 8.5 s (6 s of transfer between DNP and NMR instruments, 2 s of sample stabilization and 500 ms of measurement time). The liquid-state signal enhancement (ε) was calculated by the acquisition of a conventional 1D 13C NMR experiment with a single scan and using an excitation flip angle θ = 90°, for all four hyperpolarized and thermal equilibrium samples (entries 1–4, Table 1). To measure the thermal sample, the hyperpolarized sample was maintained for 15 minutes outside the magnet to ensure complete relaxation. It can be observed in Table 1 that the maximum signal enhancement in liquid-state conditions is achieved for the 60 mM sample, in strong agreement with the solid-state measurements.

Table 1 Liquid-state NMR enhancement ratio (ε) measured 8.5 s after the dissolution in a hot water solution of Na2EDTA (743 μM) of PA samples doped with different concentrations of radical 7, BDPA and OX63. % 13C polarization after sample dissolution was measured at 298 K and at a magnetic field of 14.1 T
Entry Radical Sat. timea [s] Pol. time [s] Liquid-state enhancement (ε) % pol 13C after dissol. η (ε/sat. time) [s−1]
a The saturation time has been taken as the time corresponding to the 98% solid-state polarization percentage estimated by the HyperSense® during the polarization build-up curve acquisition.
1 BAm-BDPA 20 mM 5400 872 1.1
2 BAm-BDPA 40 mM 3500 3600 7109 8.7 2.0
3 BAm-BDPA 60 mM 1800 2400 9358 11.4 5.2
4 BAm-BDPA 80 mM 1100 2600 6623 8.1 6.0
5 BDPA 40 mM 5400 5400 11[thin space (1/6-em)]583 14.1 2.1
6 BDPA 40 mM 5400 1800 4478 5.5 0.8
7 OX63 15 mM 3600 3600 12[thin space (1/6-em)]369 15.1 3.4
8 OX63 15 mM 3600 1800 7228 8.8 2.0


In order to compare these results with those of the non-functionalized BDPA radical and the golden standard OX63 radical, dissolution DNP experiments were also performed using these radicals in their optimal concentrations as was previously described: PA[thin space (1/6-em)]:[thin space (1/6-em)]sulfolane (1[thin space (1/6-em)]:[thin space (1/6-em)]1) doped with 40 mM of BDPA and PA doped with 15 mM of OX63. Fig. 3 shows the polarization build-up curves recorded in a HyperSense® polarizer working at 3.35 T and 1.4 K, whereas Table 1 displays the corresponding liquid-state NMR signal enhancement factors. In addition, we introduce an efficient polarization factor (η) to assess the liquid-state signal enhancement achieved by the DNP saturation time afforded during the complete dissolution DNP-NMR process (η = ε/saturation time [s], last column in Table 1).


image file: c6ra00635c-f3.tif
Fig. 3 13C polarization build-up curves at 3.35 T and 1.4 K of 20 μl PA doped with 60 mM of BAm-BDPA 7 (squares), 20 μl PA doped with 15 mM OX63 (crosses) and 20 μl 1[thin space (1/6-em)]:[thin space (1/6-em)]1 (v/v) PA[thin space (1/6-em)]:[thin space (1/6-em)]sulfolane doped with 40 mM BDPA (circles). It should be noted that the quantity of PA in the sample with BDPA is half that of the others because of its formulation.

As can be observed in Fig. 3, the polarization time required to reach the saturation plateau with a 60 mM sample of 7 is two times lower than that with the OX63 radical and three times lower than that with BDPA (entries 3, 5 and 7 in Table 1). However, the ε factor and the percentage of 13C polarization are partially lower with respect to the OX63 and BDPA radicals, mainly because the different radical concentrations could lead to different hyperpolarization decay rates. On the other hand, although the ε at a 80 mM concentration is not very high, we must not ignore that the saturation time is even shorter (1100 s; solid-state curve shown in Fig. 1b, entry 4 in Table 1), specifically, more than three times lower than OX63 and five times lower than BDPA. Thus, although the ε at both 60 mM and 80 mM show slightly lower enhancements, the use of radical 7 as a polarizing agent seems to be advantageous since it can reduce the overall experimental time with respect to OX63 and BDPA radicals, resulting in a very efficient polarizing agent. This is clearly observed by comparing the different η factors in Table 1 (entries 3, 5 and 7). Typically, the time needed to polarize a sample in a dissolution DNP experiment using the OX63 trityl radical is 60–90 min whereas with a 60 mM solution of 7 it can be significantly reduced to 30 min. This leads to economized instrumentation time and minimizes the consumption of liquid helium. Comparison of the build-up time constant (Tc) of BAm-BDPA 7 with the ones for the OX63 and BDPA radicals performed at their optimal concentration in PA (Fig. 2) shows the same tendency. Indeed, the build-up time constant for radical 7 is lower than those for OX63 and BDPA radicals, and hence the polarization time needed to polarize PA is also lower.

Taking into account the 13C polarization build-up curves of the solid-state samples (Fig. 3), a comparison of the liquid-state DNP enhancements of all three samples at short polarization times was performed. Thus, after 1800 s of polarization, all the samples were fast dissolved in a hot water dissolution with Na2EDTA (743 μM) and automatically transferred to a 600 MHz NMR spectrometer to perform the corresponding NMR measurements (entries 3, 6 and 8 in Table 1). It is worth noting that the highest signal enhancement (ε) is obtained with 7 (60 mM), and is 1.3 and 2 times higher than those of the OX63 and BDPA radicals, respectively. We could also observe that 7 is the most efficient polarizing agent as it has the highest η factor meaning an optimal compromise between a reasonable signal enhancement and a relatively short polarization time.

Conclusions

Two novel BDPA radical derivatives have been synthesized and studied as polarizing agents for fast dissolution DNP-NMR applications. The radical CN-BDPA, 5, was shown to be unstable with time and hence it is not a good polarizing agent of PA. On the other hand, the radical BAm-BDPA, 7, has proved to be a quick and efficient polarizing agent of PA without the need for a glassing agent, showing optimum levels of 13C signal NMR enhancements per polarization time unit. Its use as a polarizing agent in dissolution DNP studies can represent important savings in measurement time, optimized instrument usage and liquid helium consumption.

Material and methods

Tris{8-carboxyl-2,2,6,6-tetra[2-(1-hydroxyethyl)]-benzo(1,2-d:4,5-d′)bis(1,3)dithiole-4-yl}methyl sodium salt (OX63, Oxford Instruments Molecular Biotools, Oxford, UK), 1,3-bisdiphenylene-2-phenylallyl (BDPA) radical/benzene clathrate (1[thin space (1/6-em)]:[thin space (1/6-em)]1), [1-13C]pyruvic acid, sulfolane and all the solvents were purchased from Sigma-Aldrich Company, Ltd. (Tres Cantos, Madrid, Spain) and were used without further purification.

X-band EPR

The EPR spectra were recorded in a Bruker ELEXYS E500 X-band spectrometer equipped with a TE102 microwave cavity, a Bruker variable temperature unit, and a field-frequency (F/F) lock system (Bruker ER 033 M); line positions were determined with an NMR Gaussmeter Bruker ER 035 M. The modulation amplitude was kept well below the line width, and the microwave power was well below saturation.

Dynamic nuclear polarization

Sample preparations. (a) Radical 5 solutions: 3.54 mg of radical 5 was dissolved in 100 μl of sulfolane and then the same amount of PA (100 μl) was added, obtaining a final 40 mM concentration of the radical in the mixture. After the first trial, 3.54 mg was dissolved in 100 μl of sulfolane and benzene (80 mM). Once the radical was completely dissolved, 100 μl of PA was added, obtaining a final solution where the concentration of both the radical and benzene was 40 mM. (b) Radical 7 solutions: 1.8 mg of 7 was completely dissolved in 100 μl of PA and 0.36 μl of benzene was added. The final concentration of both 7 and benzene was 40 mM. The same protocol was followed in order to prepare solutions of 7 at all the different concentrations (20, 60 and 80 mM). (c) BDPA 8 solutions: 40 mM BDPA solutions were prepared by dissolving 4.0 mg of 8 into 100 μl of sulfolane, then 100 μl of PA was added yielding the desired concentration. (d) OX63 solutions: 15 mM solutions of OX63 were prepared by completely dissolving 2.4 mg of radical into 100 μl of PA.
Microwave sweep. The optimum positive P(+) and negative P(−) polarization peaks for each radical sample were determined by irradiating for 3 minutes at each frequency in a range from 94.000 to 94.200 GHz unless otherwise stated.
Dissolution DNP experiments. A HyperSense® (Oxford Instruments Molecular Biotools, Oxford, UK) commercial polarizer working at 3.35 T and 1.4 K was used to hyperpolarize 20 μl aliquots of each different sample. These were polarized by irradiation at the corresponding optimum positive peak P(+) determined by the 13C microwave DNP spectrum for each radical used until polarization saturation. The hyperpolarized sample was then dissolved with 4 ml of water, automatically transferred into an empty NMR tube and placed inside a Bruker AVANCE-III 600 MHz spectrometer (Bruker Biospin, Rheinstetten, Germany), previously locked and shimmed with a reference sample. The spectrometer was equipped with a 5 mm broadband TXI inverse probehead incorporating a z-gradient coil and working at a field strength of 14.1 T (600.13 and 150.03 MHz, 1H and 13C frequencies respectively). After dissolution, the polytetrafluoroethylene (PTFE) transfer pipe line was cleaned with methanol (3 × 4 ml) and then with water/Na2EDTA (743 μM) (3 × 4 ml), after each DNP experiment.
Liquid-state 13C DNP-NMR measurements. The 13C DNP-NMR spectra were acquired 8.5 s after the sample dissolution using a conventional 1D broadband, and heterodecoupled 13C spectra were recorded employing a 90° RF pulse. The data were collected into 32 K data points during an acquisition time of 0.43 s and using a spectral width of 37[thin space (1/6-em)]878 Hz in a single scan. Prior to Fourier transformation an exponential function with a line broadening of 1 Hz was applied, and the frequency-domain spectra were then manually phased and baseline corrected.

After the complete decay of polarization, a conventional 1D 13C NMR thermal equilibrium spectrum was acquired with an acquisition time of 0.43 s. The data were collected into 32 K data points, with a spectral width of 37[thin space (1/6-em)]878 Hz in a single pulse and using a 90° degree flip angle, unless otherwise stated. This was processed in the same way as the hyperpolarized 13C DNP-NMR spectrum. The liquid-state enhancements were calculated by the division of the signal integral of the hyperpolarized signal over the integral of the thermal equilibrium.

Acknowledgements

This research was supported by the DGI Grants “POMAs” (CTQ2010-19501) and “Be-Well” (CTQ2013-40480 R), MINECO (CTQ2012-32436), AGAUR Grant (2014SGR-0017) and MINECO Grant (PTA 2011-5037-I) for the subprogram Personal Técnico de Apoyo. We also thank the Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), the Consejo Superior de Investigaciones Científicas for the JAE Grant, and Amable Bernabé for his work in MALDI spectrometry. NMR studies were carried out at the joint NMR facility of the Universitat Autònoma de Barcelona and CIBER-BBN (Cerdanyola del Vallès).

Notes and references

  1. J. Kurhanewicz, D. B. Vigneron, K. Brindle, E. Y. Chekmenev, R. J. Deberardinis, G. G. Green, R. R. Rizi, B. D. Ross and W. S. Warren, Neoplasia, 2011, 13, 81 CrossRef CAS PubMed.
  2. J. H. Lee, Y. Okuno and S. Cavagnero, J. Magn. Reson., 2014, 241, 18 CrossRef CAS PubMed.
  3. F. Colegrove, L. Schearer and G. Walters, Phys. Rev., 1963, 132, 2561 CrossRef CAS.
  4. H.-U. Kauczor, R. Surkau and T. Roberts, Eur. J. Radiol., 1998, 8, 820 CrossRef CAS.
  5. S. B. Duckett and R. E. Mewis, Acc. Chem. Res., 2012, 45, 1247 CrossRef CAS PubMed.
  6. C. Bowers and D. Weitekamp, Phys. Rev. Lett., 1986, 57, 2645 CrossRef CAS PubMed.
  7. A. Abragam and M. Goldman, Rep. Prog. Phys., 1978, 41, 395 CrossRef CAS.
  8. K. H. Sze, Q. Wu, H. S. Tse and G. Zhu, Top. Curr. Chem., 2012, 326, 215 CrossRef CAS PubMed.
  9. J. H. Ardenkjær-Larsen, B. Fridlund, A. Gram, G. Hansson, L. Hansson, M. H. Lerche, R. Servin, M. Thaning and K. Golman, Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 10158 CrossRef PubMed.
  10. F. A. Gallagher, M. I. Kettunen and K. M. Brindle, Prog. Nucl. Magn. Reson. Spectrosc., 2009, 55, 285 CrossRef CAS.
  11. H. Kovacs, D. Moskau and M. Spraul, Prog. Nucl. Magn. Reson. Spectrosc., 2005, 46, 131 CrossRef CAS.
  12. M. Ragavan, H.-Y. Chen, G. Sekar and C. Hilty, Anal. Chem., 2011, 83, 6054 CrossRef CAS PubMed.
  13. S. Bowen and C. Hilty, Angew. Chem., Int. Ed. Engl., 2008, 47, 5235 CrossRef CAS PubMed.
  14. H. Zeng, Y. Lee and C. Hilty, Anal. Chem., 2010, 82, 8897 CrossRef CAS PubMed.
  15. M. H. Lerche, S. Meier, P. R. Jensen, H. Baumann, B. O. Petersen, M. Karlsson, J. O. Duus and J. H. Ardenkjaer-Larsen, J. Magn. Reson., 2010, 203, 52 CrossRef CAS PubMed.
  16. L. Frydman and D. Blazina, Nat. Phys., 2007, 3, 415 CrossRef CAS.
  17. P. Giraudeau, Y. Shrot and L. Frydman, J. Am. Chem. Soc., 2009, 131, 13902 CrossRef CAS PubMed.
  18. M. E. Merritt, C. Harrison, C. Storey, F. M. Jeffrey, D. Sherry and C. R. Malloy, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 19773 CrossRef CAS PubMed.
  19. K. M. Brindle, S. E. Bohndiek, F. A. Gallagher and M. I. Kettunen, Magn. Reson. Med., 2011, 66, 505 CrossRef PubMed.
  20. M. Karlsson, P. R. Jensen, J. Ø. Duus, S. Meier and M. H. Lerche, Appl. Magn. Reson., 2012, 43, 223 CrossRef CAS.
  21. L. Chavarria, J. Romero-Giménez, E. Monteagudo, S. Lope-Piedrafita and J. Cordoba, NMR Biomed., 2015, 28, 17 CAS.
  22. W. Jiang, L. Lumata, W. Chen, S. Zhang, Z. Kovacs, A. D. Sherry and C. Khemtong, Sci. Rep., 2015, 5, 9104 CrossRef PubMed.
  23. D. R. Anderson, J. S. Keute, H. L. Chapel and T. H. Koch, J. Am. Chem. Soc., 1979, 101, 1904 CrossRef CAS.
  24. L. Lumata, M. E. Merritt, C. R. Malloy, A. D. Sherry and Z. Kovacs, J. Phys. Chem. A, 2012, 116, 5129 CrossRef CAS PubMed.
  25. (a) C. Rovira, D. Ruiz-Molina, O. Elsner, J. Vidal-Gancedo, J. Bonvoisin, J.-P. Launay and J. Veciana, Chem.–Eur. J., 2001, 7, 240 CrossRef CAS PubMed; (b) D. Maspoch, D. Ruiz-Molina, K. Wurst, J. Vidal-Gancedo, C. Rovira and J. Veciana, Dalton Trans., 2004, 7, 1073 RSC; (c) V. Lloveras, J. Vidal-Gancedo, T. M. Figueira-Duarte, J.-F. Nierengarten, J. J. Novoa, F. Mota, N. Ventosa, C. Rovira and J. Veciana, J. Am. Chem. Soc., 2011, 133, 5818 CrossRef CAS PubMed.
  26. (a) J. L. Muñoz-Gomez, I. Marin-Montesinos, V. Lloveras, M. Pons, J. Vidal-Gancedo and J. Veciana, Org. Lett., 2014, 16, 5402 CrossRef PubMed; (b) C. Gabellieri, V. Mugnaini, P. C. Paniagua, N. Roques, M. Oliveros, M. Feliz, J. Veciana and M. Pons, Angew. Chem., Int. Ed., 2010, 49, 3360 CrossRef CAS PubMed; (c) C. Ysacco, E. Rizzato, M. A. Virolleaud, H. Karoui, A. Rockenbauer, F. Moigne, D. Siri, O. Ouai, R. G. Griffin and P. Tordo, Phys. Chem. Chem. Phys., 2010, 12, 5841 RSC; (d) E. L. Dane, B. Corzilius, E. Rizzato, P. Stocker, T. Maly, A. A. Smith, R. G. Griffin, O. Ouai, P. Tordo and T. M. Swager, J. Org. Chem., 2012, 77, 1789 CrossRef CAS PubMed; (e) O. Haze, B. Corzilius, A. A. Smith, R. G. Griffin and T. M. Swager, J. Am. Chem. Soc., 2012, 134, 14287 CrossRef CAS PubMed.
  27. J. H. Ardenkjaer-Larsen, I. Laursen, I. Leunbach, G. Ehnholm, L.-G. Wistrand, J. S. Petersson and K. Golman, J. Magn. Reson., 1998, 133, 1 CrossRef CAS PubMed.
  28. J. L. Muñoz-Gómez, E. Monteagudo, V. Lloveras, T. Parella, J. Veciana and J. Vidal-Gancedo, Org. Biomol. Chem., 2015, 13, 2689 Search PubMed.
  29. V. K. Michaelis, A. A. Smith, B. Corzilius, O. Haze, T. M. Swager and R. R. Griffin, J. Am. Chem. Soc., 2013, 135, 2935 CrossRef CAS PubMed.
  30. L. Becerra, G. Gerfen, R. Temkin, D. Singel and R. Griffin, Phys. Rev. Lett., 1993, 71, 3561 CrossRef CAS PubMed.
  31. L. Lumata, S. J. Ratnakar, A. Jindal, M. Merritt, A. Comment, C. Malloy, A. D. Sherry and Z. Kovacs, Chem.–Eur. J., 2011, 17, 10825 CrossRef CAS PubMed.
  32. C. F. Koelsch, J. Am. Chem. Soc., 1957, 79, 1165 CrossRef.
  33. D. T. Breslin and M. A. Fox, J. Phys. Chem., 1993, 97, 13341 CrossRef CAS.
  34. R. Kuhn and F. A. Neugebeauer, Monatsh. Chem., 1964, 95, 3 CrossRef CAS.
  35. M. J. Plater, S. Kemp and E. Lattmann, J. Chem. Soc., Perkin Trans. 1, 2000, 971 RSC.
  36. N. Hiroyuki, Y. Naoki, S. Yukoh, G. Ritsuko, M. Takeshi and T. Eishun, J. Macromol. Sci., Part A:Pure Appl. Chem., 1992, 29, 775 Search PubMed.
  37. S. Mullegger, M. Rashidi, M. Fattinger and R. Koch, J. Phys. Chem. C, 2012, 116, 22587 Search PubMed.
  38. N. Azuma, T. Ozawa and J. Yamauchi, J. Chem. Soc., Perkin Trans. 2, 1994, 203 RSC.
  39. L. Lumata, A. K. Jindal, M. E. Merritt, C. R. Malloy, A. D. Sherry and Z. Kovacs, J. Am. Chem. Soc., 2011, 133, 8673–8680 CrossRef CAS PubMed.

Footnotes

Electronic supplementary information (ESI) available: Synthesis and characterization of free radicals 1–7, EPR spectra of BAm-BDPA and CN-BDPA. See DOI: 10.1039/c6ra00635c
These authors have contributed equally.

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.